Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries.

LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, Gandhi S, Janmohamed A, Kumakech E, Mosqueira NR, Nguyen NQ, Paul P, Tang Y, Minh TH, Uttekar BP, Jumaan AO.

Bull World Health Organ. 2011 Nov 1;89(11):821-830B. doi: 10.2471/BLT.11.089862. Epub 2011 Sep 1.

2.

Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings.

Biellik R, Levin C, Mugisha E, LaMontagne DS, Bingham A, Kaipilyawar S, Gandhi S.

Vaccine. 2009 Oct 19;27(44):6203-9. doi: 10.1016/j.vaccine.2009.08.003. Epub 2009 Aug 19.

PMID:
19698808
3.

A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.

Hutubessy R, Levin A, Wang S, Morgan W, Ally M, John T, Broutet N.

BMC Med. 2012 Nov 13;10:136. doi: 10.1186/1741-7015-10-136.

4.

Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam.

Levin CE, Van Minh H, Odaga J, Rout SS, Ngoc DN, Menezes L, Araujo MA, LaMontagne DS.

Bull World Health Organ. 2013 Aug 1;91(8):585-92. doi: 10.2471/BLT.12.113837. Epub 2013 Jun 19.

5.

Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings.

Bingham A, Drake JK, LaMontagne DS.

Arch Pediatr Adolesc Med. 2009 May;163(5):455-61. doi: 10.1001/archpediatrics.2009.50.

PMID:
19414692
6.

Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013.

Ladner J, Besson MH, Rodrigues M, Audureau E, Saba J.

BMC Public Health. 2014 Jun 30;14:670. doi: 10.1186/1471-2458-14-670.

7.

Assessment of eight HPV vaccination programs implemented in lowest income countries.

Ladner J, Besson MH, Hampshire R, Tapert L, Chirenje M, Saba J.

BMC Public Health. 2012 May 23;12:370. doi: 10.1186/1471-2458-12-370.

8.

Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007.

Kramer MR, Dunlop AL.

Matern Child Health J. 2012 Apr;16 Suppl 1:S102-10. doi: 10.1007/s10995-012-0999-6.

PMID:
22453332
9.

A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt.

Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, Patrick DM, Naus M.

PLoS Med. 2010 May 4;7(5):e1000270. doi: 10.1371/journal.pmed.1000270.

10.

Influences on parental acceptance of HPV vaccination in demonstration projects in Uganda and Vietnam.

Galagan SR, Paul P, Menezes L, LaMontagne DS.

Vaccine. 2013 Jun 26;31(30):3072-8. doi: 10.1016/j.vaccine.2013.04.056. Epub 2013 May 15.

PMID:
23684835
11.

Achieving high coverage in Rwanda's national human papillomavirus vaccination programme.

Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, Ngabo F.

Bull World Health Organ. 2012 Aug 1;90(8):623-8. doi: 10.2471/BLT.11.097253. Epub 2012 May 23.

12.

Implementation of human papillomavirus immunization in the developing world.

Kane MA, Serrano B, de Sanjosé S, Wittet S.

Vaccine. 2012 Nov 20;30 Suppl 5:F192-200. doi: 10.1016/j.vaccine.2012.06.075. Review.

PMID:
23199963
13.

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.

Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY.

Vaccine. 2008 Jul 29;26(32):4080-93. doi: 10.1016/j.vaccine.2008.04.053. Epub 2008 May 15.

PMID:
18550229
14.

Prevalence of cervical infection with HPV type 16 and 18 in Vietnam: implications for vaccine campaign.

Vu LT, Bui D, Le HT.

BMC Cancer. 2013 Feb 4;13:53. doi: 10.1186/1471-2407-13-53.

15.

The relationship between receiving care within a medical home and HPV vaccine receipt for adolescent girls: results of the 2007 National Survey of Children's Health.

Sara Test F, Caskey R, Rankin KM.

Matern Child Health J. 2013 Feb;17(2):274-81. doi: 10.1007/s10995-012-0975-1.

PMID:
22415810
16.

[Acceptability of vaccination against human papillomavirus (HPV) by pediatricians, mothers and young women in Ho Chi Minh City, Vietnam].

Phan DP, Pham QT, Strobel M, Tran DS, Tran TL, Buisson Y.

Rev Epidemiol Sante Publique. 2012 Dec;60(6):437-46. doi: 10.1016/j.respe.2012.03.010. Epub 2012 Nov 6. French.

PMID:
23137871
17.

Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda.

Mugisha E, LaMontagne DS, Katahoire AR, Murokora D, Kumakech E, Seruyange R, Tsu VD.

Afr Health Sci. 2015 Mar;15(1):33-41. doi: 10.4314/ahs.v15i1.5.

18.

Correlates of human papillomavirus vaccine coverage: a state-level analysis.

Moss JL, Reiter PL, Brewer NT.

Sex Transm Dis. 2015 Feb;42(2):71-5. doi: 10.1097/OLQ.0000000000000225.

19.

Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program.

Demarteau N, Breuer T, Standaert B.

Pharmacoeconomics. 2012 Apr;30(4):337-53. doi: 10.2165/11591560-000000000-00000.

PMID:
22409292
20.

Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania.

Quentin W, Terris-Prestholt F, Changalucha J, Soteli S, Edmunds WJ, Hutubessy R, Ross DA, Kapiga S, Hayes R, Watson-Jones D.

BMC Med. 2012 Nov 13;10:137. doi: 10.1186/1741-7015-10-137.

Items per page

Supplemental Content

Write to the Help Desk